Gambia vs Norway: Previously treated cases tested for RR-/MDR-TB
Gambia
100.0%
in 2024
Norway
100.0%
in 2024
Gambia rank
1st
Norway rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Gambia
- Norway
How they compare
Gambia currently reports 100.0% against 100.0% in Norway, a difference of 0.0%.
The two have swapped places 6 times across 16 shared years of data; in 2006 it was Norway ahead.
Gambia ranks 1st and Norway ranks 1st of 180 countries.
Norway has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Gambia | Norway | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 52.8% | 60.8% | 8.0% | Norway |
| 2010s | 53.6% | 54.7% | 1.1% | Norway |
| 2020s | 89.4% | 89.4% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Gambia or Norway?
- Gambia, at 100.0% against 100.0% in Norway as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Gambia and Norway?
- 0.0%, with Gambia ahead.
- How many years of comparable data are there for Gambia and Norway?
- 16 years are reported by both, from 2006 to 2024.
- How do Gambia and Norway rank globally for previously treated cases tested for rr-/mdr-tb?
- Gambia ranks 1st and Norway ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.